Interest in the organism Streptococcus mutans is closely associated with its involvement in dental caries. This organism is also involved as a causative agent of endocarditis (1, 3) . Knowledge of the antibiotic susceptibility patterns of S. mutans is of importance for proper therapy in the cases of endocarditis because S. mutans endocarditis has been *in some instances confused with group D enterococcal endocarditis (3) . In one recent report, approximately 5% of streptococcal endocarditis isolates studied were S. mutans. (2) . Baker and Thornsberry (2) have reported the patterns of susceptibility ofS. mutans, isolated from patients with endocarditis, to 11 antibiotics. In this study we have determined the susceptibility of 50 strains of S. mutans, isolated from dental plaque, to 20 different antimicrobial agents.
MATERIALS AND METHODS
Bacterial strains. The bacterial strains used in this study were obtained from the dental clinics of the University of Oklahoma College of Dentistry and from C. Schaechtele, the University of Minnesota. Of the 50 strains of S. mutans, 6 were defined strains representing each known serotype and included the following: LM7, SL-1, 6715, Ingbritt, BHT, and OMZ-61. The remaining strains were isolated from samples ofdental plaque and were identified according to (i) colony morphology on Mitis Salivarius agar, (ii) fermentation of mannitol and sorbitol, and (iii) extracellular polysaccharide production in 5% sucrose broth.
Antibiotics. The antibiotics used and the sources from which they were obtained were: erythromycin, kanamycin, neomycin, novobiocin, and tetracycline (Sigma Chemical Co., St. Louis, Mo.); ampicillin, Media. The standard liquid medium used in this study was proteose peptone broth. It contained 6% proteose peptone no. 3 (Difco), 0.3% NaCl, and 0.38% Na2HPO4. After sterilization the broth was completed by the addition of three more components at the following final concentrations: 0.02% CaCl2, 0.05% glucose, and 5% normal horse serum (GIBCO). Trypticase soy broth (BBL) was also used in the initial portions of the study.
Susceptibility tests. Each strain ofS. mutans was streaked onto Mitis Salivarius agar plates, incubated at 37°C in an anaerobic jar for 24 h, and then allowed to incubate at 37°C aerobically for an additional 24 h. Several colonies with similar morphology were picked and inoculated into proteose peptone broth. After overnight incubation at 37°C, 0.1 ml of each culture was inoculated into a tube containing 10 ml of proteose peptone broth. To sterile microdilution plates containing appropriate serial dilutions of antibiotic in proteose peptone broth, 0.05 ml of the overnight diluted culture was added. Each plate was covered with clear plastic and incubated at 37°C for 48 h. Unless otherwise specified, all incubations were performed aerobically. In instances when anaerobic conditions were maintained, anaerobic Gas-Pak (BBL) jars were utilized. The minimal inhibitory concentration (MIC) was the lowest concentration of antibiotic that caused complete inhibition of growth.
RESULTS
Growth of the various strains of S. mutans was supported best in proteose peptone broth containing 5% horse serum. In comparison with other media, including Trypticase soy broth, growth of all bacterial strains was sufficient in 24 h to determine the MIC of a particular antibiotic within one dilution. To insure that maximal growth occurred, however, final MICs were routinely determined after 48 h of incubation.
There was some question whether there were any differences in growth or inhibition by antibiotics when the organism was incubated under aerobic or anaerobic conditions. To answer this question the MICs of several antibiotics (cephalothin, methicillin, and vancomycin) were determined with 50 different strains ofS. mutans incubated under both aerobic and anaerobic conditions. The results from these experiments are given in Table 1 . The average MICs obtained for each antibiotic were essentially identical with either aerobic or anaerobic incubation and indicated that the atmosphere had little effect on the growth of the organism or its susceptibility to antibiotics.
The MICs for inhibition of the 50 strains, plotted as a function of the percentage of susceptible strains, are shown in Fig. 1 through 3 . In Fig. 1 the concentration of antibiotics ranged from 0.0005 to 2 jig/ml and included penicillin, ampicillin, erythromycin, cephalothin, methicillin, rifampin, and lincomycin. The inhibitory concentrations of most of the antibiotics covered a 10-fold range from the lowest to highest concentration required for growth inhibition. With two of the antibiotics, rifampin and lincomycin, there was a 250-fold range from the lowest to highest concentration required for growth inhibition.
In Fig. 2 the concentration of antibiotics ranged from 0.01 to 10 ,ug/ml and included streptolydigan, thiostrepton, spiromycin, kanamycin, and novobiocin. A 1,000-fold range in the concentration for inhibition of growth was observed with thiostrepton and spiromycin.
In Fig. 3 the concentration of antibiotics ranged from 0.05 to 400 ,ug/ml and included tetracycline, chloramphenicol, spectinomycin, gentamicin, kanamycin, neomycin, streptomycin, and kasugamycin. A 1,000-fold range in the concentrations of tetracycline required for inhibition of growth was observed, whereas there was a more narrow range of inhibition for all other antibiotics.
DISCUSSION
The purpose of this investigation was to test the susceptibility of strains of S. mutans iso- lated from dental plaque to 20 different antimicrobial agents. In a previous study of 11 antibiotics, Baker and Thornsberry (2) Among group A streptococci there has been a world-wide increase in the number of tetracycline-resistant strains observed (4, 6) . Since tetracycline is a frequently used antibiotic, the incidence of tetracycline resistance among S. mutans may also be increasing. However, the other two antibiotics with wide ranges of MICs, thiostrepton and spiromycin, are not frequently used and one would not expect much increase in the incidence ofresistant organisms. There was no evidence of multiple drug resistance among any of the strains of S. mutans used in this study. 
